vs

Side-by-side financial comparison of Quest Diagnostics (DGX) and F&G Annuities & Life, Inc. (FG). Click either name above to swap in a different company.

Quest Diagnostics is the larger business by last-quarter revenue ($2.9B vs $1.8B, roughly 1.6× F&G Annuities & Life, Inc.). Quest Diagnostics runs the higher net margin — 9.7% vs 7.3%, a 2.5% gap on every dollar of revenue. On growth, F&G Annuities & Life, Inc. posted the faster year-over-year revenue change (13.2% vs 9.2%). Over the past eight quarters, Quest Diagnostics's revenue compounded faster (9.9% CAGR vs 6.1%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

F&G Annuities & Life, Inc. is a public company headquartered in Des Moines, Iowa. It primarily provides annuities, life insurance, and pension buyout services. The company was founded in 1959.

DGX vs FG — Head-to-Head

Bigger by revenue
DGX
DGX
1.6× larger
DGX
$2.9B
$1.8B
FG
Growing faster (revenue YoY)
FG
FG
+4.1% gap
FG
13.2%
9.2%
DGX
Higher net margin
DGX
DGX
2.5% more per $
DGX
9.7%
7.3%
FG
Faster 2-yr revenue CAGR
DGX
DGX
Annualised
DGX
9.9%
6.1%
FG

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DGX
DGX
FG
FG
Revenue
$2.9B
$1.8B
Net Profit
$281.0M
$128.0M
Gross Margin
Operating Margin
15.4%
Net Margin
9.7%
7.3%
Revenue YoY
9.2%
13.2%
Net Profit YoY
12.0%
-60.9%
EPS (diluted)
$2.24
$0.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGX
DGX
FG
FG
Q1 26
$2.9B
Q4 25
$2.8B
$1.8B
Q3 25
$2.8B
$1.7B
Q2 25
$2.8B
$1.4B
Q1 25
$2.7B
$908.0M
Q4 24
$2.6B
$1.6B
Q3 24
$2.5B
$1.4B
Q2 24
$2.4B
$1.2B
Net Profit
DGX
DGX
FG
FG
Q1 26
$281.0M
Q4 25
$245.0M
$128.0M
Q3 25
$245.0M
$118.0M
Q2 25
$282.0M
$40.0M
Q1 25
$220.0M
$-21.0M
Q4 24
$222.0M
$327.0M
Q3 24
$226.0M
$-6.0M
Q2 24
$229.0M
$203.0M
Gross Margin
DGX
DGX
FG
FG
Q1 26
Q4 25
32.4%
Q3 25
33.7%
Q2 25
34.2%
Q1 25
32.5%
Q4 24
32.7%
Q3 24
32.6%
Q2 24
33.5%
Operating Margin
DGX
DGX
FG
FG
Q1 26
15.4%
Q4 25
13.8%
Q3 25
13.7%
Q2 25
15.9%
Q1 25
13.0%
Q4 24
13.8%
Q3 24
13.3%
Q2 24
14.8%
Net Margin
DGX
DGX
FG
FG
Q1 26
9.7%
Q4 25
8.7%
7.3%
Q3 25
8.7%
7.0%
Q2 25
10.2%
2.9%
Q1 25
8.3%
-2.3%
Q4 24
8.5%
21.0%
Q3 24
9.1%
-0.4%
Q2 24
9.6%
17.3%
EPS (diluted)
DGX
DGX
FG
FG
Q1 26
$2.24
Q4 25
$2.18
$0.97
Q3 25
$2.16
$0.85
Q2 25
$2.47
$0.26
Q1 25
$1.94
$-0.20
Q4 24
$1.95
$2.53
Q3 24
$1.99
$-0.08
Q2 24
$2.03
$1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGX
DGX
FG
FG
Cash + ST InvestmentsLiquidity on hand
$393.0M
$1.5B
Total DebtLower is stronger
$5.7B
$2.2B
Stockholders' EquityBook value
$7.7B
$4.8B
Total Assets
$16.7B
$98.4B
Debt / EquityLower = less leverage
0.74×
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGX
DGX
FG
FG
Q1 26
$393.0M
Q4 25
$420.0M
$1.5B
Q3 25
$432.0M
$2.2B
Q2 25
$319.0M
$1.9B
Q1 25
$188.0M
$3.3B
Q4 24
$549.0M
$2.3B
Q3 24
$764.0M
$3.5B
Q2 24
$271.0M
$3.5B
Total Debt
DGX
DGX
FG
FG
Q1 26
$5.7B
Q4 25
$5.2B
$2.2B
Q3 25
$5.2B
$2.2B
Q2 25
$5.2B
$2.2B
Q1 25
$5.9B
$2.2B
Q4 24
$5.6B
$2.2B
Q3 24
$5.6B
$2.0B
Q2 24
$3.8B
$2.0B
Stockholders' Equity
DGX
DGX
FG
FG
Q1 26
$7.7B
Q4 25
$7.2B
$4.8B
Q3 25
$7.3B
$4.8B
Q2 25
$7.2B
$4.4B
Q1 25
$6.9B
$4.4B
Q4 24
$6.8B
$4.0B
Q3 24
$6.8B
$4.3B
Q2 24
$6.6B
$3.7B
Total Assets
DGX
DGX
FG
FG
Q1 26
$16.7B
Q4 25
$16.2B
$98.4B
Q3 25
$16.2B
$96.1B
Q2 25
$16.0B
$91.8B
Q1 25
$15.8B
$88.0B
Q4 24
$16.2B
$85.0B
Q3 24
$16.1B
$84.1B
Q2 24
$13.9B
$78.5B
Debt / Equity
DGX
DGX
FG
FG
Q1 26
0.74×
Q4 25
0.72×
0.47×
Q3 25
0.71×
0.46×
Q2 25
0.72×
0.50×
Q1 25
0.85×
0.51×
Q4 24
0.83×
0.55×
Q3 24
0.83×
0.47×
Q2 24
0.58×
0.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGX
DGX
FG
FG
Operating Cash FlowLast quarter
$278.0M
$1.2B
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.99×
9.13×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGX
DGX
FG
FG
Q1 26
$278.0M
Q4 25
$465.0M
$1.2B
Q3 25
$563.0M
$937.0M
Q2 25
$544.0M
$1.6B
Q1 25
$314.0M
$956.0M
Q4 24
$464.0M
$1.3B
Q3 24
$356.0M
$2.1B
Q2 24
$360.0M
$1.1B
Free Cash Flow
DGX
DGX
FG
FG
Q1 26
Q4 25
$307.0M
Q3 25
$419.0M
Q2 25
$436.0M
Q1 25
$197.0M
Q4 24
$341.0M
Q3 24
$250.0M
Q2 24
$268.0M
FCF Margin
DGX
DGX
FG
FG
Q1 26
Q4 25
10.9%
Q3 25
14.9%
Q2 25
15.8%
Q1 25
7.4%
Q4 24
13.0%
Q3 24
10.0%
Q2 24
11.2%
Capex Intensity
DGX
DGX
FG
FG
Q1 26
3.9%
Q4 25
5.6%
Q3 25
5.1%
Q2 25
3.9%
Q1 25
4.4%
Q4 24
4.7%
Q3 24
4.3%
Q2 24
3.8%
Cash Conversion
DGX
DGX
FG
FG
Q1 26
0.99×
Q4 25
1.90×
9.13×
Q3 25
2.30×
7.94×
Q2 25
1.93×
40.50×
Q1 25
1.43×
Q4 24
2.09×
4.04×
Q3 24
1.58×
Q2 24
1.57×
5.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons